Richard Krasuski, MD, FACC, FAHA, FESC, FSCAI

Richard A. Krasuski, MD, FACC, FAHA, FESC, FSCAI is the Schar Family Endowed Chair of Adult Congenital Heart Disease at the Inova Heart and Vascular Institute. He is also Adjunct Professor of Medicine and Pediatrics at Duke University Health System. He is certified by the ABIM as Diplomate in ACHD, Cardiovascular Disease and Internal Medicine. Dr. Krasuski received his medical degree from Harvard and then completed a residency in internal medicine at Brigham & Women’s Hospital and a cardiology fellowship at Duke. He actively served in the US Air Force 2001-2005, where he was Researcher of the Year in 2004 and the youngest finalist ever for the Gold Headed Cane Award for academic, clinical and research excellence in 2005. From 2005-2015 he directed the ACHD program and collaborated with the PH program at the Cleveland Clinic. In 2013 he received the Bruce Hubbard Stewart Award “in recognition of the ability to combine sensitivity and compassion with knowledge and skill in the practice of medicine.” From 2015-2026 he led the ACHD program at Duke and was the director of the CTEPH program. He was recruited by Inova in 2026 to coordinate the congenital heart disease program. He performs structural and congenital heart interventions including balloon pulmonary angioplasty in CTEPH. He currently serves on editorials boards/is a reviewer for >20 leading medical publications and has authored or co-authored >400 peer-reviewed articles, abstracts and book chapters related to his specialty interests. He has also helped to develop extensive materials for patient and physician education including expert guideline documents and has been an invited professor or lecturer at over 100 major medical centers worldwide.
Financial relationships
-
Attribution:SelfType of financial relationship:Consulting FeeIneligible company:Gore MedicalTopic:Occluder DevicesDate added:09/24/2026Date updated:09/24/2026
-
Attribution:SelfType of financial relationship:Consulting FeeIneligible company:MedtronicTopic:Transcatheter ValvesDate added:09/24/2026Date updated:09/24/2026
-
Attribution:SelfType of financial relationship:Consulting FeeIneligible company:Gradient Denervation TechnologiesTopic:Pulmonary DenervationDate added:09/24/2026Date updated:09/24/2026
-
Attribution:SelfType of financial relationship:Contracted ResearchIneligible company:JanssenTopic:Pulmonary HypertensionDate added:09/24/2026Date updated:09/24/2026
-
Attribution:SelfType of financial relationship:OtherIneligible company:LiquidiaTopic:Inhalational Therapy for PAHDate added:09/24/2026Date updated:09/24/2026
-
Attribution:SelfType of financial relationship:OtherIneligible company:MerckTopic:Pulmonary HypertensionDate added:09/24/2026Date updated:09/24/2026
-
Attribution:SelfType of financial relationship:Contracted ResearchIneligible company:Edwards Life SciencesTopic:Transcatheter ValvesDate added:09/24/2026Date updated:09/24/2026
-
Attribution:SelfType of financial relationship:Contracted ResearchIneligible company:MedtronicTopic:Transcatheter ValvesDate added:09/24/2026Date updated:09/24/2026

Facebook
X
LinkedIn
Forward